Slideshow ( 2 images )(Reuters) – Gilead Sciences Inc and rival Merck & Co Inc said on Monday they will test a combination of their experimental HIV drugs to develop a long-acting treatment for the infection that affects millions worldwide. As part of the non-exclusive agreement, the companies hope to develop a therapy that allows